Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

11.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
Ligand Binding Sites02:40

Ligand Binding Sites

6.0K
6.0K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

10.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
10.6K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.3K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.3K
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

2.5K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.5K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

19.3K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
19.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[On the molecular drug design from viewpoint of precision medicine].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same author

[Concise analysis for innovation of pioneering and follow-on drugs].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same author

[Drug innovation and reverse thinking].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same author

[Application of temperature sensitive yeast models with definite target in the screening of potential human Pin1 inhibitors].

Yao xue xue bao = Acta pharmaceutica Sinica·2014
Same author

[Challenges and strategies of drug innovation].

Yao xue xue bao = Acta pharmaceutica Sinica·2013
Same author

[Modification of natural products for drug discovery].

Yao xue xue bao = Acta pharmaceutica Sinica·2012
Same journal

[The protective effects of curcumin loaded mesoporous silica nanoparticles on rat cardiomyocytes].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Identification of water buffalo horn and its adulterants using COI barcode].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Construction of the brain-targeting drug carrier through imprinting of nicotinic acetylcholine receptor α7].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Application of magnetic iron oxide nanoparticles in magnetic resonance / photothermal dual-modal imaging].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Endocytosis pathway and intracellular distribution of heparosan].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[On-line detection of concentration process of Ganmaoling granules by near infrared spectroscopy combined with automatic control system].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
See all related articles

Related Experiment Video

Updated: May 1, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

[Ligand efficiency and lead optimization].

Zong-Ru Guo

    Yao Xue Xue Bao = Acta Pharmaceutica Sinica
    |April 3, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Optimizing drug discovery requires evaluating molecular structure and macroscopic properties. This overview highlights thermodynamic signatures and binding kinetics for better compound quality and drug development.

    More Related Videos

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
    14:34

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

    Published on: April 3, 2026

    300
    Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
    09:30

    Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

    Published on: July 19, 2024

    2.9K

    Related Experiment Videos

    Last Updated: May 1, 2026

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
    10:29

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

    Published on: May 9, 2025

    2.0K
    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
    14:34

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

    Published on: April 3, 2026

    300
    Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
    09:30

    Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

    Published on: July 19, 2024

    2.9K

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Drug Discovery

    Background:

    • Pharmacological activity and druggability are key to drug innovation, influenced by molecular structure and properties.
    • Optimizing molecular structures presents challenges due to multi-dimensional complexities and in vitro to in vivo response uncertainties.

    Purpose of the Study:

    • To explore the role of thermodynamic signatures and binding kinetics in drug-receptor interactions.
    • To emphasize the importance of these parameters in optimizing compound quality during lead optimization.

    Main Methods:

    • Reviewing existing literature on thermodynamic signatures and binding kinetics in drug discovery.
    • Analyzing how these parameters relate to molecular structure and macroscopic properties.
    • Discussing multi-parameter metrics for evaluating compound efficiency.

    Main Results:

    • Thermodynamic signatures and binding kinetics offer crucial insights into drug-receptor interactions.
    • These kinetic and thermodynamic factors are significant for improving compound quality.
    • Integrating these parameters aids in optimizing molecular structures for effective drug discovery.

    Conclusions:

    • Thermodynamic signatures and binding kinetics are vital for assessing and enhancing drug candidates.
    • A multi-parameter approach, including these factors, is essential for successful lead optimization.
    • Focusing on microscopic structural optimization guided by these signatures improves drug discovery outcomes.